Your prediction
Pros and Cons of Atea ASA in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atea ASA vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atea ASA | 0.130% | 6.317% | 3.670% | 30.528% | 19.848% | 31.177% | -0.753% |
| ELF Beauty Inc | 1.780% | 6.603% | 10.226% | -33.895% | 5.003% | -32.679% | - |
| Natural Grocers By Vit. Cot. | 0.700% | 11.719% | 5.926% | -12.805% | 33.645% | 157.658% | 202.646% |
| Designer Brands Inc. | -0.930% | 13.347% | 5.941% | 115.726% | -18.321% | -41.209% | -54.661% |
News
Atea Pharmaceuticals Q1 Earnings Call Highlights
Atea Pharmaceuticals (NASDAQ:AVIR) said it remains on track for two key Phase 3 hepatitis C readouts in 2026 while advancing a newer hepatitis E program aimed at immunocompromised patients with no
